Cargando…
Successful Retreatment With ADOC Chemotherapy in Relapsed Thymic Carcinoma: Experiences in Two Cases
The optimal second-line chemotherapeutic regimen for thymic carcinoma remains uncertain and predictive factors for the response have not been identified. We encountered two cases of relapsed thymic carcinoma with recurrence 1.5 and 8 years after initial response to cisplatin/doxorubicin/vincristine/...
Autores principales: | Nomura, Yayoi, Koizumi, Tomonobu, Kitaguchi, Akihiro, Horiuchi, Toshimichi, Kanda, Shintarou, Yamamoto, Hiroshi, Hanaoka, Masayuki, Kubo, Keishi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649833/ https://www.ncbi.nlm.nih.gov/pubmed/29147275 http://dx.doi.org/10.4021/wjon435w |
Ejemplares similares
-
Cisplatin plus Docetaxel Chemotherapy for Thoracic Lymph Node Metastasis from Cancer of Unknown Primary – Experience of Three Cases
por: Kobayashi, Takashi, et al.
Publicado: (2009) -
Superior mesenteric artery syndrome following initiation of cisplatin-containing chemotherapy: a case report
por: Ushiki, Atsuhito, et al.
Publicado: (2012) -
Association of lung immune prognostic index with survival outcome in advanced thymic carcinoma patients treated with palliative intent chemotherapy
por: Araki, Taisuke, et al.
Publicado: (2022) -
Diffuse Endobronchial Wall Spread of Metastatic Breast Cancer
por: Koizumi, Tomonobu, et al.
Publicado: (2009) -
Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease
por: Fujimoto, Keisaku, et al.
Publicado: (2011)